For example, metformin, a novel drug candidate for cancer prevention, is proved to inhibit mTOR signaling [78], and low expression of organic cation transporter 3 (OCT3/SLC22A3), a metformin uptake transporter [77, 79] causes resistance to metformin. This evidence concerns the gene SLC22A3 and cancer.